Sino Biopharmaceutical Limited (HKG:1177)
5.17
-0.19 (-3.46%)
Oct 14, 2026, 4:08 PM HKT
Sino Biopharmaceutical Employees
Sino Biopharmaceutical had 22,838 employees as of June 30, 2026. That makes Sino Biopharmaceutical the 1,611th largest employer in the world and 148th in Hong Kong.
Employees
22,838
Change
n/a
Growth
n/a
Revenue / Employee
1.70M HKD
Profits / Employee
120.78K HKD
Market Cap
91.99B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 22,838 | - | - |
| Dec 31, 2025 | 21,435 | -2,944 | -12.08% |
| Dec 31, 2024 | 24,379 | -1,427 | -5.53% |
| Dec 31, 2023 | 25,806 | -466 | -1.77% |
| Dec 31, 2022 | 26,272 | 693 | 2.71% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| WuXi Biologics | 14,705 |
| BeOne Medicines AG | 12,000 |
| Innovent Biologics | 8,754 |
| Genscript Biotech | 6,135 |
| 3SBio | 6,068 |
| Akeso | 4,082 |
| Shanghai Henlius Biotech | 4,082 |
| RemeGen | 3,145 |
Sino Biopharmaceutical News
- 1 month ago - Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion - PRNewsWire
- 1 month ago - Sino Biopharmaceutical Earnings release: H1 2026 - Filings
- 1 month ago - Sino Biopharmaceutical Quarterly report: H1 2026 - Filings
- 3 months ago - Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs - Reuters
- 3 months ago - AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal - WSJ
- 3 months ago - Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion - Reuters
- 5 months ago - GSK enters into exclusive strategic collaboration with Sino Biopharm - TheFly
- 5 months ago - GSK to team up with Sino Biopharma for China launch of hepatitis B treatment - Reuters